PRME
Price
$3.13
Change
-$0.12 (-3.70%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
577.61M
59 days until earnings call
RXRX
Price
$4.67
Change
-$0.04 (-0.85%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
2.04B
64 days until earnings call
Interact to see
Advertisement

PRME vs RXRX

Header iconPRME vs RXRX Comparison
Open Charts PRME vs RXRXBanner chart's image
Prime Medicine
Price$3.13
Change-$0.12 (-3.70%)
Volume$28.73K
Capitalization577.61M
Recursion Pharmaceuticals
Price$4.67
Change-$0.04 (-0.85%)
Volume$52.12K
Capitalization2.04B
PRME vs RXRX Comparison Chart in %
Loading...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRME vs. RXRX commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRME is a Hold and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (PRME: $3.24 vs. RXRX: $4.70)
Brand notoriety: PRME and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRME: 66% vs. RXRX: 63%
Market capitalization -- PRME: $577.61M vs. RXRX: $2.04B
PRME [@Biotechnology] is valued at $577.61M. RXRX’s [@Biotechnology] market capitalization is $2.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRME’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • PRME’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both PRME and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRME’s TA Score shows that 1 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • PRME’s TA Score: 1 bullish, 5 bearish.
  • RXRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than PRME.

Price Growth

PRME (@Biotechnology) experienced а -8.73% price change this week, while RXRX (@Biotechnology) price change was -4.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

PRME is expected to report earnings on Oct 31, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.04B) has a higher market cap than PRME($578M). PRME YTD gains are higher at: 10.959 vs. RXRX (-30.473). PRME has higher annual earnings (EBITDA): -197.38M vs. RXRX (-583.64M). RXRX has more cash in the bank: 525M vs. PRME (102M). RXRX has less debt than PRME: RXRX (88.1M) vs PRME (120M). RXRX has higher revenues than PRME: RXRX (64.5M) vs PRME (4.96M).
PRMERXRXPRME / RXRX
Capitalization578M2.04B28%
EBITDA-197.38M-583.64M34%
Gain YTD10.959-30.473-36%
P/E RatioN/AN/A-
Revenue4.96M64.5M8%
Total Cash102M525M19%
Total Debt120M88.1M136%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRMERXRX
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
83%
Momentum
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
89%
MACD
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
88%
Aroon
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HHDFX36.65-0.02
-0.05%
Hamlin High Dividend Equity Instl
JLVIX75.41-0.24
-0.32%
JHancock Fundamental Large Cap Core I
RPMAX16.25-0.09
-0.55%
Reinhart Genesis PMV Investor
FMEFX43.98-0.40
-0.90%
Nuveen Small/Mid Cap Growth Opp R6
RPNIX11.21-0.18
-1.58%
Riverpark/Next Century Gr Inst

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
-5.81%
CRSP - PRME
58%
Loosely correlated
-2.30%
BEAM - PRME
54%
Loosely correlated
-2.91%
RXRX - PRME
53%
Loosely correlated
-3.39%
CRBU - PRME
48%
Loosely correlated
-3.61%
EDIT - PRME
46%
Loosely correlated
-3.02%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-3.39%
CRSP - RXRX
68%
Closely correlated
-2.30%
BEAM - RXRX
63%
Loosely correlated
-2.91%
ABSI - RXRX
62%
Loosely correlated
-3.24%
ABCL - RXRX
58%
Loosely correlated
-2.79%
NTLA - RXRX
55%
Loosely correlated
-2.11%
More